Fibroblast growth factor receptor 1 (FGFR1) amplification is one of the most promising findings in ESCC genomic studies due to the availability of FGFR inhibitors and its association with response to FGFR inhibitor treatment [12, 13]. The gene discussed is FGFR1; the disease is esophageal squamous cell carcinoma.